Objective:

To characterize the clinical attributes, diagnostic challenges, and therapeutic complexities of pediatric esophageal squamous cell carcinoma and evaluate the feasibility of adapting adult treatment frameworks, particularly in terms of clinical management and outcomes.

Key Findings:

• Pediatric esophageal squamous cell carcinoma is rare and often diagnosed at an advanced stage, necessitating urgent clinical awareness.
• Clinical manifestations are non-specific, leading to frequent misdiagnosis, which can delay treatment.
• No standardized treatment protocols exist for pediatric cases, differing significantly from adult tumors, highlighting the need for tailored approaches.

Interpretation:

The findings highlight the need for customized diagnostic and treatment approaches for pediatric esophageal cancer, as it presents distinct clinical and biological characteristics compared to adults, which may affect treatment efficacy.

Limitations:

• The rarity of pediatric esophageal cancer limits the availability of comprehensive clinical data, which may affect the generalizability of findings.
• Current treatment strategies are primarily based on adult studies and isolated pediatric cases, which may not fully address the unique needs of pediatric patients.

Conclusion:

A comprehensive approach combining neoadjuvant chemoradiotherapy with surgery may improve outcomes, but further research is needed to establish effective treatment protocols for pediatric patients, particularly in identifying optimal timing for surgical intervention.